In this module, we will highlight clinical practice guidelines and will explore, at class level, conventional and advanced treatments for IBD. We will also review the concept of therapeutic drug monitoring (TDM) when caring for patients with IBD.
IBD Treatment Landscape
potato 2
-
IBD Treatment Landscape
-
In this chapter, we’ll explore the classes of conventional treatments available when caring for patients with IBD, focusing specifically on aminosalicylates, corticosteroids, and immunomodulators. We will also explain how these came to be a part of the practitioner’s tool kit for disease management.
Presented by Kimberly Kearns, MS, APN-BC
-
In this chapter, you will receive a comprehensive review of advanced monitoring techniques, including therapeutic drug monitoring (TDM), for managing biologic therapy. This presentation also includes an analysis of advanced personalized medicine approaches in IBD treatment, including assessing biomarkers and genetics.
Presented by Andres J. Yarur, MD
-
-
Here you will find quick links to a few of the clinical practice guidelines for the management of Crohn’s disease (CD) from US-based medical associations.
ACG Clinical Guideline: Management of Crohn’s Disease in Adults
-
Here you will find quick links to a few of the clinical practice guidelines for the management of ulcerative colitis (UC) from US-based medical associations.
ACG Clinical Guideline: Ulcerative Colitis in Adults
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
AGA’s Mild-to-Moderate Clinical Decision Support Tool
AGA Spotlight: Management of Moderate to Severe Ulcerative Colitis
-
In this chapter, we’ll explore the classes of biologic and small molecule treatments available for the care of patients with IBD as well as the clinical guidelines for use.
Create an account to receive updates Coming in 2025